aCROnordic merges with Ecron Acunova

Wednesday, May 18, 2011 12:01 PM

Ecron Acunova, a full-service international CRO, will merge with Danish aCROnordic, specialized in Nordic clinical research.

Ecron Acunova is based in bio-science park, near Copen­hagen. Søren Strøh, founder of aCROnordic, will continue his role as CEO. 

CEO Søren Strøh stated: "aCROnordic goes global as the first Danish CRO.  We may offer international clinical services and a flexible cost effective high quality approach leveraging resources in Asia and Europe without potential cultural barriers. We expect to attract international clinical trial projects offering access to Nordic sites and highly qualified clinical research experience and skills."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs